HLA-mismatched cellular therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HLA-mismatched cellular therapy, covering 2025-02-05 to 2025-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL [Phase 1]